Echo KB
← Section II · Valvular Heart Disease
II.C

Echo-Doppler Assessment of Prosthetic Heart Valves

36 cards

Notes

Types

Mechanical prostheses

  • Ball-and-cage (Starr-Edwards) - obsolete but historically tested. Flow AROUND the cage; higher peak velocities; central 'closing volume' regurg jet.
  • Single-tilting disc (Björk-Shiley, Medtronic Hall) - two orifices (major + minor).
  • Bileaflet tilting disc (St Jude, On-X, Carbomedics) - 3 orifices, usually three small regurgitant "washing" jets that clean the hinges.

Bioprosthetic (tissue) valves

  • Homograft/allograft (human aortic root).
  • Autograft - Ross procedure (patient's own PV moved to AV position). Late risk: autograft regurgitation.
  • Xenograft - porcine aortic (Hancock, Carpentier-Edwards) or bovine pericardial (Perimount).
  • Stented vs stentless (stented: struts visible → likely bioprosthesis).
  • Trileaflet; very low physiologic regurgitant volume.

TAVR

  • Balloon-expandable (Edwards Sapien) - implanted 2–4 mm below the annulus.
  • Self-expanding (Medtronic CoreValve, Evolut) - implanted 3–6 mm below the annulus.
  • Normal DVI after TAVR often > 0.45.

Post-op imaging schedule

  • Class I: initial TTE 2–4 weeks after AVR/MVR (or 6–12 weeks for some references) to establish baseline.
  • Repeat TTE any time there is a change in symptoms or exam.
  • Annual TTE for bioprosthetic valves after year 10 (not routine for mechanical valves).

Normal prosthetic hemodynamics

  • All prosthetic valves are mildly obstructive by design (AVA typically 1–2 cm²).
  • Bileaflet mechanical valves have physiologic hinge-washing regurgitation.
  • Peak aortic prosthetic velocity is normally < 3 m/s.
  • Microcavitations (microbubbles) are commonly seen with normally functioning bileaflet mechanicals - not artifact.
  • Central occluder double spectral profile: use the brighter, higher-velocity portion (this represents the true valve flow, not the low-velocity signal through the central orifice).

Doppler assessment - key parameters

Aortic prosthesis

  • Peak velocity < 3 m/s normal; > 4 m/s concerning.
  • Doppler velocity index (DVI) = V_LVOT / V_jet. Normal ≥ 0.35 (or ≥ 0.30 for smaller valves); < 0.25 suggests significant obstruction. Flow-independent, prosthesis-size independent.
  • Acceleration time (AT) - onset of flow to peak. Normal < 100 ms; > 100 ms suggests pathologic obstruction.
  • AT/ET > 0.4 → obstruction.
  • CW jet contour:
    • Triangular / pointed early peak → normal, or functional obstruction (high output, pressure recovery, PPM), or pathologic regurgitation.
    • Rounded, mid-systolic peak (parabolic) → pathologic obstruction.
  • iEOA = AVA / BSA. Patient-prosthesis mismatch (PPM):
    • Aortic PPM present: iEOA < 0.85 cm²/m².
    • Severe PPM: iEOA < 0.65 cm²/m².
  • LVOT PW should be placed 0.5–1 cm below the sewing ring; LVOT diameter measured inner-to-inner below the suture line.

Mitral prosthesis

  • Normal mean gradient ≈ 3–5 mmHg at HR 60–80.
  • Elevated E velocity ≥ 1.9 m/s = prosthesis dysfunction.
  • VTI ratio (VTI_prosthesis / VTI_LVOT):
    • ≥ 2.2 → dysfunction.
    • ≥ 2.5 with EOA < 1.0 cm² → significant mitral prosthesis stenosis.
  • PHT:
    • PHT ≥ 130 ms → PATHOLOGIC OBSTRUCTION.
    • PHT < 130 ms with VTI ratio ≥ 2.2 → suggests pathologic REGURGITATION (rapid E, but PHT still short because equalization is fast when the LA-LV volume gradient is regurgitation-driven).
  • Never use PHT to compute mitral prosthesis EOA - tends to overestimate. Use the continuity equation: EOA = (CSA_LVOT × VTI_LVOT) / VTI_prosthesis (requires no significant AR or MR).
  • Mitral PPM: iEOA ≤ 1.2 (moderate), ≤ 0.9 (severe). PHT is normal in PPM.
  • Dehiscence: prosthetic MV rocking > 15° on 3D → dehiscence.

Regurgitation categorization

  • Physiologic = built-in washing jets of mechanical valves + closing volume - small, symmetric, often multiple.
  • Central pathologic - usually bioprosthetic (leaflet degeneration or endocarditis).
  • Paravalvular (peri-prosthetic) - outside the sewing ring; always pathologic. Common after debridement, redo procedures, older patients, TAVR (small paravalvular after TAVR occurs in 5–20 %).

Thrombus vs pannus

ThrombusPannus
Duration of symptomsAcuteGradual, late
SizeLargerSmall
DensitySoft, similar to myocardiumDense, echogenic
PositionMechanical > bioprosthetic; more mitralAortic > mitral
MovementMobileFixed
Response to anticoagulationYesNo - surgical
  • Thrombus < 0.85 cm² is less likely to embolize but may respond to lytic/anticoag.

Aortic prosthetic endocarditis

  • Vegetation/abscess most commonly causes AR (less commonly AV block, MI).

Pressure recovery - prosthetic valves

  • Most common in small mechanical bileaflet AV prostheses and small aortic roots. Doppler will read higher gradient than cath; adjust EOA upward.

High valve gradients - differential

  • Pathologic obstruction: degenerative stenosis, pannus, thrombus.
  • Functional obstruction: high cardiac output, patient-prosthesis mismatch, pressure recovery (small bileaflet).
  • Pathologic regurgitation: increased flow through the valve raises the gradient (as in native VHD).

Aortic regurgitation index (post-TAVR, cath)

  • ARI = (DBP − LV EDP) / SBP × 100.
  • ARI < 25 → poor prognosis.

Cards

  • basicII.C-001
    Name the three mechanical valve types and describe flow through each.
    1) Ball-and-cage (Starr-Edwards) — flow around the cage, high peak velocities, central closing regurgitant jet. 2) Single tilting-disc — two orifices (major and minor). 3) Bileaflet tilting-disc (St Jude, On-X) — three orifices with three physiologic 'washing' regurgitant jets.
  • basicII.C-002
    What is a Ross procedure and what long-term complication is characteristic?
    Ross procedure = autograft replacement of the aortic valve using the patient's own pulmonary valve (a pulmonary homograft is placed in the pulmonary position). Late complication: autograft aortic regurgitation.
  • basicII.C-003
    How deep from the annulus are balloon-expandable (Sapien) and self-expanding (CoreValve/Evolut) TAVR valves typically deployed?
    Sapien: 2–4 mm below the annulus. CoreValve/Evolut: 3–6 mm below the annulus.
  • basicII.C-004
    What is the recommended post-operative TTE follow-up schedule for bioprosthetic vs mechanical valves?
    Both: initial TTE 2–4 weeks postoperatively to establish baseline. Bioprosthetic: annual TTE after 10 years. Mechanical: only if a change in symptoms or exam.
  • basicII.C-005
    What is a normal peak velocity across an aortic prosthesis?
    Less than 3 m/s. Velocities > 4 m/s or discordant DVI/AT suggest obstruction or PPM.
  • basicII.C-006
    Define the Doppler velocity index (DVI) for aortic and mitral prostheses.
    Aortic: V_LVOT / V_jet (or VTI_LVOT / VTI_jet). Mitral: V_jet / V_LVOT. Aortic normal DVI ≥ 0.35; < 0.25 suggests obstruction. Mitral VTI ratio > 2.2 abnormal.
  • basicII.C-007
    Why is the DVI preferred over gradient alone for aortic prosthesis evaluation?
    It is FLOW-independent and PROSTHESIS-SIZE independent — corrects for high output, PPM, small prostheses that would otherwise inflate gradient readings.
  • basicII.C-008
    What acceleration time cutoff on the aortic prosthesis CW jet suggests pathologic obstruction?
    AT > 100 ms suggests pathologic obstruction. Also: AT/ET > 0.4 indicates obstruction.
  • basicII.C-009
    Contrast the CW jet contour of a normal vs pathologically obstructed aortic prosthesis.
    Normal (or high-flow, PPM, pressure recovery): triangular/pointed early-peaking jet. Pathologic obstruction: rounded, mid-systolic (parabolic) peak.
  • basicII.C-010
    Define iEOA and the thresholds for aortic patient-prosthesis mismatch.
    iEOA = EOA / BSA. Aortic PPM present: iEOA < 0.85 cm²/m². Severe PPM: iEOA < 0.65 cm²/m². (Mitral PPM: < 1.2 moderate; < 0.9 severe.)
  • basicII.C-011
    Why does patient-prosthesis mismatch develop and why is it not a valve malfunction?
    PPM occurs when a normal, structurally intact prosthesis has an EOA too small for the patient's cardiac output demand (small valve in a large body). It reflects a size mismatch, not a mechanical valve problem.
  • basicII.C-012
    What is the single most important Doppler finding for pathologic obstruction of a mitral prosthesis?
    PHT ≥ 130 ms. This single value is the strongest indicator of pathologic mitral prosthesis obstruction.
  • basicII.C-013
    E velocity ≥ 1.9 m/s and VTI ratio ≥ 2.2 on a mitral prosthesis with a NORMAL PHT (< 130 ms) — most likely diagnosis?
    Significant mitral prosthesis REGURGITATION. Elevated flow raises E and VTI ratio, but PHT remains short because there is no true obstruction to LV filling.
  • basicII.C-014
    Which equation should be used to calculate mitral prosthesis EOA — continuity or PHT?
    Continuity equation: EOA = (CSA_LVOT × VTI_LVOT) / VTI_prosthesis. PHT-derived MVA overestimates prosthesis EOA and should NOT be used.
  • basicII.C-015
    When is the continuity equation invalid for prosthesis EOA?
    When significant AR or MR is present — LVOT-derived flow no longer equals valve flow.
  • basicII.C-016
    Are microcavitations seen with mechanical valves pathologic?
    No — microcavitations (microbubbles) are commonly seen with NORMALLY functioning bileaflet mechanical valves, especially on harmonic imaging.
  • basicII.C-017
    Distinguish paravalvular from central prosthetic regurgitation.
    Central: originates within the prosthesis. Small central 'washing' jets are normal for mechanical valves; larger central jets suggest bioprosthetic degeneration or endocarditis. Paravalvular: originates outside the sewing ring — ALWAYS pathologic.
  • basicII.C-018
    Compare echocardiographic features of prosthetic valve thrombus vs pannus.
    Thrombus: acute onset symptoms, larger, soft (similar echogenicity to myocardium), more common in mechanical mitral, mobile — may respond to anticoagulation. Pannus: gradual chronic symptoms, small, dense/echogenic, more common in aortic position, fixed — requires surgery.
  • basicII.C-019
    Prosthetic aortic valve endocarditis with vegetation or root abscess most commonly causes what hemodynamic complication?
    Aortic regurgitation. Less commonly AV block or acute MI from coronary compromise.
  • basicII.C-020
    In which scenario is prosthetic-valve pressure recovery most clinically significant?
    Small mechanical bileaflet aortic prostheses in patients with a small ascending aorta. Doppler overestimates gradient (and underestimates EOA) relative to catheter measurements.
  • basicII.C-021
    What degree of prosthetic mitral valve 'rocking' motion suggests dehiscence?
    Rocking motion > 15° across the annulus (best assessed by 3D echo). This is the gold-standard imaging finding for prosthetic MV dehiscence.
  • basicII.C-022
    How do you handle a mechanical mitral prosthesis with a 'double spectral' Doppler profile?
    Use the BRIGHTER (higher-velocity) portion of the profile for gradient calculation — this represents true transvalvular flow. The lower-velocity signal is central/orifice-related.
  • basicII.C-023
    Age criteria that generally favor a BIOPROSTHESIS vs a MECHANICAL valve?
    Bioprosthesis favored: age > 70 (low structural deterioration risk, avoid long-term anticoagulation). Mechanical favored: age < 50 (bioprosthesis has 15-y structural failure ~30% at age 40, 50% at age 20).
  • basicII.C-024
    Which additional patient factors favor a bioprosthetic vs mechanical valve?
    Bioprosthesis: high bleeding risk on anticoagulation, limited access to INR monitoring, non-compliance, small aortic root (allows future valve-in-valve TAVR). Mechanical: existing indication for anticoagulation (AF), high reoperation risk, compliant with INR.
  • basicII.C-025
    What is the aortic regurgitation index (post-TAVR) and its cutoff for poor prognosis?
    ARI = (Diastolic BP − LV end-diastolic pressure) / SBP × 100. ARI < 25 is associated with worse post-TAVR outcomes (measured invasively in the cath lab).
  • basicII.C-026
    State two prosthetic valve findings that always warrant urgent evaluation.
    Paravalvular regurgitation (always pathologic), and new hemolytic anemia with schistocytes/helmet cells (suggests high-shear paravalvular leak).
  • basicII.C-027
    What features on TEE distinguish valvular from paravalvular regurgitation in a prosthetic MV?
    Valvular: jet originates within the sewing ring, sometimes central (bileaflet washing jets are normal). Paravalvular: jet originates OUTSIDE the sewing ring. Paravalvular is ALWAYS pathologic; small paravalvular (5–20%) is common after TAVR.
  • basicII.C-028
    State the normal peak velocity across a normally functioning bileaflet mechanical mitral prosthesis.
    Peak E velocity < 1.9 m/s. Mean gradient 3–5 mmHg at HR 60–80. VTI ratio (prosthetic/LVOT) < 2.2. Peak velocities ≥ 1.9 m/s or gradient ≥ 6 mmHg with elevated VTI ratio suggests significant obstruction or high flow.
  • basicII.C-029
    After TAVR, which imaging finding requires prompt investigation?
    1) New moderate or greater paravalvular AR. 2) New severe AS (leaflet thrombosis?). 3) Worsening EF or new wall-motion abnormality (coronary obstruction). 4) Pericardial effusion.
  • basicII.C-030
    How is subclinical leaflet thrombosis (SLT) after TAVR detected?
    Cardiac CT — hypoattenuated leaflet thickening (HALT) and reduced leaflet motion (RELM). Not always detectable on echo. Rising valve gradients on TTE prompt CT evaluation.
  • basicII.C-031
    Which prosthesis is at highest risk of hemolysis and why?
    Older mechanical valves (Björk-Shiley, older ball-and-cage) and any prosthesis with high-shear flow (small orifice + high gradient + paravalvular jet). Schistocytes and helmet cells on peripheral smear + elevated LDH signal hemolysis.
  • basicII.C-032
    After bioprosthetic valve implantation, how do the transvalvular gradient and DVI change with age?
    Over decades: leaflet degeneration (calcification, thickening) → progressively increased peak velocity and mean gradient, decreased DVI (< 0.25 for AV or > 2.5 VTI ratio for MV). Valve-in-valve TAVR often considered.
  • basicII.C-033
    State the 2020 ACC/AHA anticoagulation recommendations for mechanical mitral vs mechanical aortic valves.
    Mechanical mitral: warfarin INR target 3.0 (range 2.5–3.5) + low-dose aspirin. Mechanical aortic bileaflet (St Jude, On-X): INR target 2.5 (range 2.0–3.0) + low-dose aspirin. DOACs are NOT approved for mechanical valves.
  • basicII.C-034
    Why is the acceleration time on the aortic prosthesis CW jet a marker of pathologic obstruction?
    A pathologically obstructed prosthesis has resistance to ejection → the jet takes longer to reach peak velocity. AT > 100 ms suggests pathologic obstruction; AT ≤ 100 ms is normal (or high-flow / PPM / pathologic regurg).
  • basicII.C-035
    How do bileaflet mechanical mitral valves normally appear on Doppler?
    Three central regurgitant 'washing' jets from the hinges; peak E < 1.9 m/s; normal DVI. Physiologic microcavitations from bubble formation are visible on harmonic imaging — not pathologic.
  • basicII.C-036
    What are two hallmarks of a normally functioning post-Ross procedure?
    1) Pulmonary autograft (native PV) now in aortic position — often develops progressive dilation and neo-AR over decades. 2) Pulmonary homograft in RV outflow — may develop RVOT PS or PR. Long-term surveillance is essential.